Medacta Group SA

LSE:0A05 Stock Report

Market Cap: CHF 2.1b

Medacta Group Past Earnings Performance

Past criteria checks 2/6

Medacta Group has been growing earnings at an average annual rate of 18.1%, while the Medical Equipment industry saw earnings growing at 1.9% annually. Revenues have been growing at an average rate of 14% per year. Medacta Group's return on equity is 16.3%, and it has net margins of 10.3%.

Key information

18.1%

Earnings growth rate

20.5%

EPS growth rate

Medical Equipment Industry Growth-9.5%
Revenue growth rate14.0%
Return on equity16.3%
Net Margin10.3%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Medacta Group makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

LSE:0A05 Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 245445627120
31 Mar 245285226219
31 Dec 235114725219
30 Sep 234964924517
30 Jun 234815023717
31 Mar 234594822816
31 Dec 224374622015
30 Sep 224174721214
30 Jun 223974720314
31 Mar 223804919312
31 Dec 213635218211
30 Sep 213545417310
30 Jun 21345571648
31 Mar 21324471607
31 Dec 20302371557
30 Sep 20298241667
30 Jun 20294101777
31 Mar 20302111778
31 Dec 19311121768
30 Sep 19301221626
30 Jun 19291331475
31 Mar 19282391435
31 Dec 18273461394
31 Dec 17245331293
31 Dec 16219391133

Quality Earnings: 0A05 has high quality earnings.

Growing Profit Margin: 0A05's current net profit margins (10.3%) are lower than last year (10.3%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 0A05's earnings have grown by 18.1% per year over the past 5 years.

Accelerating Growth: 0A05's earnings growth over the past year (13%) is below its 5-year average (18.1% per year).

Earnings vs Industry: 0A05 earnings growth over the past year (13%) did not outperform the Medical Equipment industry 39.9%.

Return on Equity

High ROE: 0A05's Return on Equity (16.3%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 14:33
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medacta Group SA is covered by 11 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Samuel EnglandBerenberg
Christoph GretlerCredit Suisse
David AdlingtonJ.P. Morgan